跳转至内容
Merck
CN
  • Tiagabine improves hippocampal long-term depression in rat pups subjected to prenatal inflammation.

Tiagabine improves hippocampal long-term depression in rat pups subjected to prenatal inflammation.

PloS one (2014-09-04)
Aline Rideau Batista Novais, Nadine Crouzin, Mélanie Cavalier, Mathilde Boubal, Janique Guiramand, Catherine Cohen-Solal, Marie-Céleste de Jesus Ferreira, Gilles Cambonie, Michel Vignes, Gérard Barbanel
摘要

Maternal inflammation during pregnancy is associated with the later development of cognitive and behavioral impairment in the offspring, reminiscent of the traits of schizophrenia or autism spectrum disorders. Hippocampal long-term potentiation and long-term depression of glutamatergic synapses are respectively involved in memory formation and consolidation. In male rats, maternal inflammation with lipopolysaccharide (LPS) led to a premature loss of long-term depression, occurring between 12 and 25 postnatal days instead of after the first postnatal month, and aberrant occurrence of long-term potentiation. We hypothesized this would be related to GABAergic system impairment. Sprague Dawley rats received either LPS or isotonic saline ip on gestational day 19. Male offspring's hippocampus was studied between 12 and 25 postnatal days. Morphological and functional analyses demonstrated that prenatal LPS triggered a deficit of hippocampal GABAergic interneurons, associated with presynaptic GABAergic transmission deficiency in male offspring. Increasing ambient GABA by impairing GABA reuptake with tiagabine did not interact with the low frequency-induced long-term depression in control animals but fully prevented its impairment in male offspring of LPS-challenged dams. Tiagabine furthermore prevented the aberrant occurrence of paired-pulse triggered long-term potentiation in these rats. Deficiency in GABA seems to be central to the dysregulation of synaptic plasticity observed in juvenile in utero LPS-challenged rats. Modulating GABAergic tone may be a possible therapeutic strategy at this developmental stage.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
碳酸氢钠, ACS reagent, ≥99.7%
Sigma-Aldrich
碳酸氢钠, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
碳酸氢钠, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
氯化钠, Molecular Biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
氯化钠 溶液, 5 M in H2O, BioReagent, Molecular Biology, suitable for cell culture
Sigma-Aldrich
氯化钠, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
氯化钠, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
氯化钠 溶液, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
氯化钠 溶液, 5 M
Sigma-Aldrich
碳酸氢钠, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.7%
Sigma-Aldrich
碳酸氢钠, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
氯化钠, BioUltra, Molecular Biology, ≥99.5% (AT)
Sigma-Aldrich
氯化钠, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%
Sigma-Aldrich
氯化钠 溶液, BioUltra, Molecular Biology, ~5 M in H2O
Sigma-Aldrich
氯化钠, 99.999% trace metals basis
Supelco
氯化钠, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
碳酸氢钠, BioXtra, 99.5-100.5%
Supelco
氯化钠, reference material for titrimetry, certified by BAM, >99.5%
USP
碳酸氢钠, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
氯化钠, BioPerformance Certified, ≥99% (titration), suitable for insect cell culture, suitable for plant cell culture
Sigma-Aldrich
氯化钠 溶液, 0.85%
Sigma-Aldrich
氯化钠, tested according to Ph. Eur.
Sigma-Aldrich
碳酸氢钠, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
碳酸氢钠, −40-+140 mesh, ≥95%
Sigma-Aldrich
碳酸氢钠, tested according to Ph. Eur.
谷氨酸, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
氯化钠-35Cl, 99 atom % 35Cl
Sigma-Aldrich
氯化钠, tablet
Sigma-Aldrich
重碳酸钠-12C, 99.9 atom % 12C
Sigma-Aldrich
氯化钠, random crystals, 99.9% trace metals basis